J. Nicolas, Hypersensibilité aux médicaments, Rev. Prat, vol.65, pp.967-989, 2015.

F. Ranchon and A. Gouraud, DRESS syndrome ou syndrome d'hypersensibilité médicamenteuse : importance et difficultés du diagnostic précoce, 2009.

J. R. Sullivan and N. H. Shear, The drug hypersensitivity syndrome : what is the pathogenesis ?, Arch. Dermatol, vol.137, issue.3, pp.357-364, 2001.

Y. A. Tehrany, E. Lafitte, O. Grosgurin, and D. Spoerl, Syndrome DRESS (drug reaction with eosinophilia and systemic symptoms), Rev. Med. Suisse, vol.12, pp.684-690, 2016.

E. Begon and J. Roujeau, Syndrome d'hypersensibilité médicamenteuse ou DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms), Ann. Dermatol. Vénéréologie, vol.131, issue.3, pp.293-297, 2004.

A. Hiransuthikul, T. Rattananupong, J. Klaewsongkram, P. Rerknimitr, M. Pongprutthipan et al., Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) : 11 years retrospective study in Thailand, Allergol. Int, vol.65, issue.4, pp.432-438, 2016.

S. Tas and T. Simonart, Drug rash with eosinophilia and systemic symptoms (DRESS syndrome), Acta Clin. Belg, vol.54, issue.4, pp.197-200, 1999.

E. López-rocha, Prevalence of DRESS syndrome, Rev. Alerg. Mex. Tecamachalco Puebla Mex, vol.61, issue.1, pp.14-23, 1993.

C. Prins and L. French, Vous avez dit «DRESS» ? Une nouvelle approche du syndrome d'hypersensibilité médicamenteuse, Rev. Médicale Suisse, vol.2434, 2003.

S. Cosconéa, N. Franck, and P. Sogni, Syndrome DRESS et atteinte hépatique, Lett. Hépato-Gastroentérologue, vol.15, issue.3, pp.140-142, 2012.

B. Lebrun-vignes and L. Valeyrie-allanore, Toxidermies, Rev. Médecine Interne, vol.36, issue.4, pp.256-270, 2015.

W. J. Pichler, Syndrome DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) Une allergie médicamenteuse grave souvent méconnue, Forum Med Suisse, vol.11, issue.48, pp.879-884, 2011.

Y. Chen, Y. Cho, C. Chang, and C. Chu, Drug reaction with eosinophilia and systemic symptoms: A drug-induced hypersensitivity syndrome with variable clinical features, Dermatol. Sin, vol.31, issue.4, pp.196-204, 2013.

P. R. Criado, R. F. Criado, J. De-m.-avancini, and C. G. Santi, Drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS) : a review of current concepts, An. Bras. Dermatol, vol.87, issue.3, pp.435-449, 2012.

, Orientation diagnostique devant un syndrome mononucléosique

. Laboratoire-d'hématologie-du-chu-d'angers, Hyperéosinophilie franche

Y. Aihara, S. Ito, Y. Kobayashi, Y. Yamakawa, M. Aihara et al., Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction, Br. J. Dermatol, vol.149, issue.1, pp.165-169, 2003.

Y. Kano, M. Seishima, and T. Shiohara, Hypogammaglobulinemia as an early sign of drug-induced hypersensitivity syndrome, J. Am. Acad. Dermatol, vol.55, issue.4, pp.727-728, 2006.

H. Bocquet, M. Bagot, and J. C. Roujeau, Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms : DRESS), Semin. Cutan. Med. Surg, vol.15, issue.4, pp.250-257, 1996.

W. Syn, D. J. Naisbitt, A. P. Holt, M. Pirmohamed, and D. J. Mutimer, Carbamazepine-induced acute liver failure as part of the DRESS syndrome, Int. J. Clin. Pract, vol.59, issue.8, pp.988-991, 2005.

E. Knudtson, M. Para, H. Boswell, and P. Fan-havard, Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus, Obstet. Gynecol, vol.101, issue.5, pp.1094-1097, 2003.

H. Hagiya, Reactivation of Human Herpes Virus-6 in the Renal Tissue of a Patient with Drug-induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms (DIHS/DRESS), Intern. Med, vol.55, issue.13, pp.1769-1774, 2016.

D. Morikawa, E. Hiraoka, K. Obunai, and Y. Norisue, Myocarditis Associated with Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome : A Case Report and Review of the Literature, Am. J. Case Rep, vol.19, pp.978-984, 2018.

E. Rubenstein, Myocardite éosinophilique avec défaillance multiviscérale dans le cadre d'un DRESS : premier cas dû à la Lamotrigine ®, Rev. Médecine Interne, vol.35, p.84, 2014.

J. Roujeau, L. Allanore, Y. Liss, and M. Mockenhaupt, Severe cutaneous adverse reactions to drugs (SCAR) : definitions, diagnostic criteria, genetic predisposition, Dermatol Sin, vol.27, issue.2, pp.203-212, 2009.

S. H. Kardaun, Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist ?, Br. J. Dermatol, vol.156, issue.3, pp.609-611, 2007.

H. Peyrière, Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?, Br. J. Dermatol, vol.155, issue.2, pp.422-428, 2006.

V. Descamps, Prise en charge du drug reaction with eosinophilia and systemic symptoms (DRESS), Ann. Dermatol. Vénéréologie, vol.137, issue.11, pp.703-708, 2010.

T. Shiohara, M. Iijima, Z. Ikezawa, and K. Hashimoto, The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations, Br. J. Dermatol, vol.156, issue.5, pp.1083-1084, 2007.

T. Shiohara, M. Inaoka, and Y. Kano, Drug-induced Hypersensitivity Syndrome (DIHS) : A Reaction Induced by a Complex Interplay among Herpesviruses and Antiviral and Antidrug Immune Responses, Allergol. Int, vol.55, issue.1, pp.1-8, 2006.

D. Picard, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) : A Multiorgan Antiviral T Cell Response, Sci. Transl. Med, vol.2, issue.46, pp.46-62, 2010.

P. Joly, Le syndrome d'hypersensibilité médicamenteuse : une réactivation virale endogène et non une allergie !, Rev. Médecine Interne, vol.32, issue.1, pp.1-2, 2011.

T. Ishida, Y. Kano, Y. Mizukawa, and T. Shiohara, The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome, Allergy, vol.69, issue.6, pp.798-805, 2014.

V. Descamps, Drug reaction with eosinophilia and systemic symptoms (DRESS) et human herpesvirus 6 (HHV-6), J. Anti-Infect, vol.18, issue.2, pp.64-69, 2016.

V. Descamps, Association of Human Herpesvirus 6 Infection With Drug Reaction With Eosinophilia and Systemic Symptoms, Arch. Dermatol, vol.137, issue.3, pp.301-304, 2001.

J. Augusto, A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis, Nephrol. Dial. Transplant, vol.24, issue.9, p.85, 2009.

K. Miyashita, Involvement of Human Herpesvirus 6 Infection in Renal Dysfunction Associated with DIHS/DRESS, Acta Derm. Venereol, vol.96, issue.1, pp.114-115, 2016.

L. Mardivirin, V. Descamps, A. Lacroix, S. Delebassée, and S. Ranger-rogez, Early effects of drugs responsible for DRESS on HHV-6 replication in vitro, J. Clin. Virol, vol.46, issue.3, pp.300-302, 2009.

L. Mardivirin, Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) : report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro, Eur. J. Dermatol, vol.20, issue.1, pp.68-73, 2010.

V. Descamps, Réactivations virales et DRESS, 2011.

W. J. Pichler, Drug Hypersensitivity Reactions: Classification and Relationship to T-Cell Activation, Drug Hypersensitivity, pp.168-189, 2007.

R. Abe, Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis, J. Dermatol, vol.42, issue.1, pp.42-48, 2015.

P. Demoly, Les allergies médicamenteuses, Médecine ThérapeutiquePédiatrie, vol.10, issue.1, pp.34-43, 2007.

W. J. Pichler, Delayed Drug Hypersensitivity Reactions, Ann. Intern. Med, vol.139, issue.8, p.683, 2003.

W. J. Pichler, Modes of presentation of chemical neoantigens to the immune system, Toxicology, pp.49-54, 2002.

J. C. Roujeau, J. M. Bonnetblanc, J. L. Schmutz, and B. Crickx, Iatrogénie. Diagnostic et prévention, Ann Dermatol Venereol, vol.129, pp.2-163, 2002.

E. Collet and B. Bonniaud, Les 7 toxidermies : présentation clinique, Rev. Fr. Allergol, vol.56, issue.3, pp.109-111, 2016.

N. Brahimi, E. Maubec, T. Petit, B. Crickx, and V. Descamps, Pustulose exanthématique aiguë généralisée induite par le phloroglucinol (Spasfon ® ), Ann. Dermatol. Vénéréologie, vol.144, issue.6, pp.423-425, 2017.

J. Roujeau, Syndromes de Lyell et de Stevens-Johnson, Rev. Prat, vol.57, issue.11, p.1165, 2007.

, Iatrogénie. Diagnostic et prévention. Toxidermies ou réactions cutanées médicamenteuses

M. Cariou, Dress (Drug reaction with eosinophilia and systemic symptoms) suite à la prise de vancomycine : à propos d'un cas, Annales de Biologie Clinique, vol.71, pp.190-195, 2013.

M. M. Avram and M. Hoang, Case 20-2009 -A 79-Year-Old Woman with a Blistering Cutaneous Eruption, N. Engl. J. Med, vol.360, issue.26, pp.2771-2777, 2009.

M. Sarre, M. Drouet, Y. L. Corre, and L. Martin, Un cas de maladie sérique attribuée à un aéro-allergène, Ann. Dermatol. Vénéréologie, vol.142, issue.12, 2015.

P. Karmacharya, Rituximab-induced serum sickness : A systematic review, Semin. Arthritis Rheum, vol.45, issue.3, pp.334-340, 2015.

A. Tripathi and P. A. Greenberger, Bupropion hydrochloride induced serum sicknesslike reaction, Ann. Allergy. Asthma. Immunol, vol.83, issue.2, pp.165-166, 1999.

I. Marie, Lupus, polymyosites, dermatomyosites et syndrome de Sjögren d'origine médicamenteuse et toxique, Médecine Thérapeutique, vol.14, issue.4, pp.237-246, 2008.

C. Masson, T. Couchouron, and M. Audran, Lupus induits, Rev. Rhum, vol.72, issue.2, pp.168-175, 2005.

A. Combes, Myocardites aiguës, Presse Médicale, vol.41, issue.6, pp.621-627, 2012.

Y. Cho, C. Yang, and C. Chu, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) : An Interplay among Drugs, Viruses, and Immune System, Int. J. Mol. Sci, vol.18, issue.6, 2017.

B. Fatrez, Méningo-encéphalite herpétique compliquant un DRESS, Ann. Dermatol. Vénéréologie, vol.144, issue.12, pp.145-146, 2017.

S. G. Kosseifi, B. Guha, D. N. Nassour, D. S. Chi, and G. Krishnaswamy, The Dapsone Hypersensitivity Syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations, J. Occup. Med. Toxicol. Lond. Engl, vol.1, p.9, 2006.

N. Favrolt, Syndrome d'hypersensibilité médicamenteuse avec manifestations systémiques sévères après traitement par minocycline, Rev. Mal. Respir, vol.24, issue.7, pp.892-895, 2007.

R. J. Atkinson, G. Dennis, S. S. Cross, M. E. Mcalindon, B. Sharrack et al., Eosinophilic colitis complicating anti-epileptic hypersensitivity syndrome: an indication for colonoscopy ?, Gastrointest. Endosc, vol.60, issue.6, pp.1034-1036, 2004.

I. A. Eland, A. S. Dofferhoff, R. Vink, P. E. Zondervan, and B. H. Stricker, Colitis May Be Part of the Antiepileptic Drug Hypersensitivity Syndrome, vol.40, pp.1780-1783, 1999.

C. Balatsinou, Eosinophilic esophagitis is a component of the anticonvulsant hypersensitivity syndrome : Description of two cases, Dig. Liver Dis, vol.40, issue.2, pp.145-148, 2008.

M. C. Carroll, K. A. Yueng-yue, N. B. Esterly, and B. A. Drolet, Drug-Induced Hypersensitivity Syndrome in Pediatric Patients, PEDIATRICS, vol.108, issue.2, pp.485-492, 2001.

I. Lin, Liver injury in patients with DRESS : A clinical study of 72 cases, J. Am. Acad. Dermatol, vol.72, issue.6, pp.984-991, 2015.

C. Ang, Y. Wang, E. M. Yoosuff, and Y. Tay, Retrospective analysis of drug-induced hypersensitivity syndrome : A study of 27 patients, J. Am. Acad. Dermatol, vol.63, issue.2, pp.219-227, 2010.

Y. Kano, T. Ishida, K. Hirahara, and T. Shiohara, Visceral Involvements and Longterm Sequelae in Drug-induced Hypersensitivity Syndrome, Med. Clin. North Am, vol.94, issue.4, pp.743-759, 2010.

L. M. Sommers and R. B. Schoene, Allopurinol Hypersensitivity Syndrome Associated With Pancreatic Exocrine Abnormalities and New-Onset Diabetes Mellitus, Arch. Intern. Med, vol.162, issue.10, pp.1190-1192, 2002.

C. Chiou, Clinicopathlogical features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan, J. Eur. Acad. Dermatol. Venereol, vol.22, issue.9, pp.1044-1049, 2008.

I. Gentile, M. Talamo, and G. Borgia, Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation ? Report of a case and literature review, BMC Infect. Dis, vol.10, p.49, 2010.

C. Chou, L. Valeyrie-allanore, V. Descamps, S. Amarger, D. Staumont-sallé et al., Syndrome d'activation macrophagique : une complication méconnue du DRESS, Ann. Dermatol. Vénéréologie, vol.141, issue.12, pp.275-276, 2014.

Y. Chen, H. Chiu, and C. Chu, Drug reaction with eosinophilia and systemic symptoms : a retrospective study of 60 cases, Arch. Dermatol, vol.146, issue.12, pp.1373-1379, 2010.

P. Cacoub, The DRESS Syndrome : A Literature Review, Am. J. Med, vol.124, issue.7, pp.588-597, 2011.

X. Wang, Lamotrigine induced DIHS/DRESS : Manifestations, treatment, and outcome in 57 patients, Clin. Neurol. Neurosurg, vol.138, pp.1-7, 1988.

B. Blaszczyk, M. Szpringer, S. J. Czuczwar, and W. Laso?, Single centre 20 year survey of antiepileptic drug-induced hypersensitivity reactions, Pharmacol. Rep, vol.65, issue.2, pp.399-409, 2013.

H. Taillia, Syndrome d'hypersensibilité aux antiépileptiques. Cas particulier de la lamotrigine, Rev. Neurol, vol.165, issue.10, pp.821-827, 2009.

M. Saha, S. Gorai, and V. Madhab, Oxcarbazepine-induced drug rash with eosinophilia and systemic symptoms syndrome presenting as exfoliative dermatitis, J. Pharmacol. Pharmacother, vol.7, issue.3, pp.142-145, 2016.

K. N. Naveen, M. S. Ravindra, V. V. Pai, V. Rai, S. B. Athanikar et al., Lamotrigine induced DRESS syndrome, Indian J. Pharmacol, vol.44, issue.6, pp.798-800, 2012.

V. Vila-nova, C. Cotta, G. Da-ponte, and S. Mendes, 1738 -The lethal potential of lamotrigine -dress syndrome, Eur. Psychiatry, vol.28, p.1, 2013.

N. Schaub and A. J. Bircher, Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro, Allergy, vol.55, issue.2, pp.191-193, 2000.

Y. Fujita, Acute Kidney Injury Caused by Zonisamide-Induced Hypersensitivity Syndrome, Intern. Med, vol.49, issue.5, pp.409-413, 2010.

R. J. Brown, Minocycline-Induced Drug Hypersensitivity Syndrome Followed by Multiple Autoimmune Sequelae, Arch. Dermatol, vol.145, issue.1, pp.63-66, 2009.

, Minocycline, restriction d'utilisation et modalités de prescription, p.20, 2018.

C. Mailhol, C. Tremeau-martinage, C. Paul, A. Godel, L. Lamant et al., DRESS syndrome sous doxycycline, Ann. Dermatol. Vénéréologie, vol.137, issue.1, pp.40-43, 2010.

D. T. Robles, Severe Drug Hypersensitivity Reaction in a Young Woman Treated with Doxycycline, Dermatology, vol.217, issue.1, pp.23-26, 2008.

A. Pal, S. Sen, A. Biswas, S. M. Naser, and S. K. Tripathi, A rare case of DRESS syndrome caused by vancomycin, J. Acute Med, vol.5, issue.3, pp.74-76, 2015.

K. S. Fields, M. J. Petersen, E. Chiao, and P. Tristani-firouzi, Case reports : treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG), J. Drugs Dermatol. JDD, vol.4, issue.4, pp.510-513, 2005.

A. Angel-moreno-maroto, L. Suárez-castellano, M. Hernández-cabrera, and J. Pérez-arellano, Severe efavirenz-induced hypersensitivity syndrome (not-DRESS) with acute renal failure, J. Infect, vol.52, issue.2, pp.39-40, 2006.

P. Bossi, D. Colin, F. Bricaire, and E. Caumes, Hypersensitivity Syndrome Associated with Efavirenz Therapy, Clin. Infect. Dis, vol.30, issue.1, pp.227-228, 2000.

J. D. Ma, K. C. Lee, and G. M. Kuo, HLA-B*5701 testing to predict abacavir hypersensitivity, PLoS Curr, vol.2, 2010.

E. J. Phillips, W. Chung, M. Mockenhaupt, J. Roujeau, and S. A. , Drug hypersensitivity : Pharmacogenetics and clinical syndromes, J. Allergy Clin. Immunol, vol.127, issue.3, pp.60-66, 2011.

S. Valade, DRESS syndrome à la phénylbutazone, Rev. Médecine Interne, vol.30, issue.8, pp.708-710, 2009.

F. Michel, J. Navellou, D. Ferraud, E. Toussirot, and D. Wendling, DRESS syndrome sous traitement par sulfasalazine au cours de la polyarthrite rhumatoïde, Rev. Rhum, vol.72, issue.1, pp.92-96, 2005.

M. L. Bouyssou-gauthier, C. Bédane, S. Boulinguez, and J. M. Bonnetblanc, Photosensitivity with sulfasalazopyridine hypersensitivity syndrome, Dermatol. Basel Switz, vol.198, issue.4, pp.388-390, 1999.

A. A. Mihas, D. J. Goldenberg, and R. L. Slaughter, Sulfasalazine Toxic Reactions : Hepatitis, Fever, and Skin Rash With Hypocomplementemia and Immune Complexes, JAMA, vol.239, issue.24, pp.2590-2591, 1978.

R. P. Sotolongo, L. I. Neefe, C. Rudzki, and K. G. Ishak, Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity, Gastroenterology, vol.75, issue.1, pp.95-99, 1978.

M. Tohyama, Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6, Arch. Dermatol, vol.134, issue.9, pp.1113-1117, 1998.

H. J. Milionis, A. Skopelitou, and M. S. Elisaf, Hypersensitivity syndrome caused by amitriptyline administration, Postgrad. Med. J, vol.76, issue.896, pp.361-363, 2000.

F. Beer, Réactions cutanées aux médicaments utilisés en cardiologie, Derm. Mag, vol.1, issue.1, pp.35-39, 2013.

M. Korbi, DRESS à l'allopurinol compliqué d'un syndrome d'activation macrophagique, Ann. Dermatol. Vénéréologie, vol.142, issue.12, pp.767-770, 2015.

R. Shalom, S. Rimbroth, D. Rozenman, and A. Markel, Allopurinol-induced recurrent DRESS syndrome : pathophysiology and treatment, Ren. Fail, vol.30, issue.3, pp.327-329, 2008.

S. Yaylac?, M. V. Demir, T. Temiz, A. Tamer, and M. I. Uslan, Allopurinol-induced DRESS syndrome, Indian J. Pharmacol, vol.44, issue.3, p.90, 2012.

J. Z. Singer and S. L. Wallace, The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality, Arthritis Rheum, vol.29, issue.1, pp.82-87, 1986.

S. Itha, A. Kumar, S. Dhingra, and G. Choudhuri, Dapsone induced cholangitis as a part of dapsone syndrome : a case report, BMC Gastroenterol, vol.3, issue.1, p.21, 2003.

K. V. Vinod, K. Arun, and T. K. Dutta, Dapsone hypersensitivity syndrome : A rare life threatening complication of dapsone therapy, J. Pharmacol. Pharmacother, vol.4, issue.2, pp.158-160, 2013.

P. Cacoub, V. Descamps, O. Meyer, C. Speirs, P. Belissa-mathiot et al., Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate, Osteoporos. Int, vol.24, issue.5, pp.1751-1757, 2013.

M. Gréco, Syndrome d'hypersensibilité médicamenteuse à l'Hexaquine ® (quinine et thiamine), Ann. Dermatol. Vénéréologie, vol.133, issue.4, pp.354-358, 2008.

L. Colas, G. Veyrac, M. Munch, P. Jolliet, and C. Bernier, Étude des cas de DRESS associés à des produits de contraste iodés (PCI) à partir de la base nationale de pharmacovigilance, Rev. Fr. Allergol, vol.56, issue.3, p.294, 2016.

Y. Arimone, Réactualisation de la méthode française d'imputabilité des effets indésirables des médicaments, Therapies, vol.66, issue.6, pp.517-525, 2011.

G. Miremont-salamé, H. Théophile, F. Haramburu, and B. Bégaud, Imputabilité en pharmacovigilance : de la méthode française originelle aux méthodes réactualisées, Therapies, vol.71, issue.2, pp.171-178, 2016.

V. Descamps, S. Ranger-rogez, P. Musette, and A. Barbaud, Le DRESS (drug reaction with eosinophilia and systemic symptoms) : une synergie médicaments-virus qui peut conduire en réanimation, Réanimation, vol.20, issue.3, pp.223-227, 2011.

C. Tran, S. R. Knowles, B. A. Liu, and N. H. Shear, Gender Differences in Adverse Drug Reactions, J. Clin. Pharmacol, vol.38, issue.11, pp.1003-1009, 1998.

N. Daadaa, Les toxidermies sévères : une série de 74 cas, Rev. Médecine Interne, vol.38, pp.147-148, 2017.

D. Kim and Y. Koh, Comparison of Diagnostic Criteria and Determination of Prognostic Factors for Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome, Allergy Asthma Immunol. Res, vol.6, issue.3, pp.216-221, 2014.

A. Chaabane, K. Aouam, N. B. Fredj, and N. A. Boughattas, DRESS syndrome : étude de 11 cas et revue de la littérature, Thérapie, vol.65, issue.6, p.91, 2010.

L. R. Grando, T. A. Schmitt, and R. M. Bakos, Severe cutaneous reactions to drugs in the setting of a general hospital, An. Bras. Dermatol, vol.89, issue.5, pp.758-762, 2014.

V. Descamps, L. Mardivirin, B. Janela, P. Musette, and S. Ranger-rogez, Le syndrome d'hypersensibilité (DRESS) n'est qu'une maladie virale, Rev. Fr. Allergol, vol.50, issue.3, pp.171-173, 2010.

G. Ozturk, B. G. Turk, B. Senturk, M. Turkmen, and G. Kandiloglu, Exanthematous drug eruption due to valsartan, Cutan. Ocul. Toxicol, 2012.

T. Lachgar and Y. Touil, Allerg. Immunol. (Leipz.), vol.33, issue.4, pp.173-175, 2001.

W. Chebbi, J. Souissi, J. Chelli, F. Larbi, B. Zantour et al., DRESS syndrome : à propos de trois observations, Pan Afr. Med. J, vol.19, 2014.

M. Sanchez-gonzalez, J. Barbarroja-escudero, D. Antolin-amerigo, T. Bellon-heredia, V. Lerma-hambleton et al., DRESS syndrome induced by piperacillin-tazobactam, Clin. Transl. Allergy, vol.4, p.96, 2014.

O. Calderón, DRESS Syndrome Induced by Piperacillin-Tazobactam in Eight Patients, J. Allergy Clin. Immunol, vol.131, issue.2, p.172, 2013.

R. Cabañas, Piperacillin-induced DRESS : distinguishing features observed in a clinical and allergy study of 8 patients, J. Investig. Allergol. Clin. Immunol, vol.24, issue.6, pp.425-430, 2014.

S. Jridi, R. Azzeddine, and J. E. Bourkadi, Le DRESS syndrome secondaire aux antituberculeux : à propos d'un cas, Pan Afr. Med. J, vol.27, 2017.

I. Khouaja, E. Guermazi, D. Béjar, H. Kwas, and H. Ghedira, DRESS syndrome aux antituberculeux, Rev. Fr. Allergol, vol.55, issue.3, p.245, 2015.

P. Komericki, R. Grims, B. Kränke, and W. Aberer, Acute generalized exanthematous pustulosis from dalteparin, J. Am. Acad. Dermatol, vol.57, issue.4, pp.718-721, 2007.

R. M. Nanau and M. G. Neuman, Ibuprofen-induced hypersensitivity syndrome, Transl. Res, vol.155, issue.6, pp.275-293, 2010.

R. Razanapinaritra, F. E. Fetoiki, F. Hali, and S. Chiheb, DRESS syndrome au clobazam chez l'enfant : un nouveau cas, Rev. Fr. Allergol, 2019.

S. Savard, S. Desmeules, J. Riopel, and M. Agharazii, Linezolid-Associated Acute Interstitial Nephritis and Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome, Am. J. Kidney Dis, vol.54, issue.6, p.92, 2009.

S. Mehta and M. Davis-lorton, P023 Clindamycin associated drug rash with eosinophilia and systemic symptoms (dress syndrome) with remnant elevated IGE, Ann. Allergy. Asthma. Immunol, vol.117, issue.5, pp.28-29, 2016.

C. Loussaief, DRESS syndrome induit par la téicoplanine, Rev. Fr. Allergol, vol.55, issue.4, pp.308-311, 2015.

A. Samain, First case of drug rash eosinophilia and systemic symptoms due to boceprevir, J. Hepatol, vol.60, issue.4, pp.891-893, 2014.

M. Sharkawi and N. Abbasakoor, A Curious Manifestation of Amoxicillin-Induced DRESS Syndrome, Chest, vol.146, issue.4, p.781, 2014.

C. Antia, L. Persad, and A. Alikhan, Trimethoprim-Sulfamethoxazole-Induced Drug Eruption With Eosinophilia and Systemic Symptoms (DRESS), J. Drugs Dermatol. JDD, vol.16, issue.10, pp.1043-1046, 2017.

W. Martanto and J. Y. Pan, Severe DRESS syndrome secondary to sulfamethoxazole/trimethoprim complicated by hyperthyroidism, photosensitivity, anhidrosis, and juvenile idiopathic arthritis, Dermatol. Sin, vol.33, issue.1, pp.33-34, 2015.

L. Hazell and S. A. Shakir, Under-reporting of adverse drug reactions : a systematic review, Drug Saf, vol.29, issue.5, pp.385-396, 2006.

B. Bégaud, K. Martin, F. Haramburu, and N. Moore, Rates of Spontaneous Reporting of Adverse Drug Reactions in France, JAMA, vol.288, issue.13, pp.1588-1588, 2002.

J. Montastruc, New methods for studying drug associated risk : experience of the Toulouse Regional Pharmacovigilance Center, Bull. Acad. Natl. Med, vol.189, issue.3, pp.493-502, 2005.